Personalized prostate cancer screening for diverse populations
Tailored prostate cancer screening: addressing USPSTF priority research gaps in a racially-diverse study population
This study is looking at a new way to screen for prostate cancer by using men's initial PSA levels to better understand their risk, especially focusing on Black men who are more likely to develop aggressive forms of the disease, with the hope of making screening safer and more effective for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10892880 on NIH RePORTER |
What this research studies
This research investigates a tailored approach to prostate cancer screening that uses men's baseline PSA levels to assess their risk of developing aggressive forms of the disease. By focusing on a racially diverse population, particularly Black men who are at higher risk, the study aims to optimize screening intervals and strategies to reduce over-diagnosis and over-treatment. Participants will be monitored over time to evaluate the effectiveness of this risk-stratified screening method, which is supported by some health advisory agencies but requires further validation. The goal is to provide a more efficient and effective screening process that benefits all men, especially those at higher risk.
Who could benefit from this research
Good fit: Ideal candidates for this research include men, particularly those from racially diverse backgrounds, who are at risk for prostate cancer.
Not a fit: Patients who are not at risk for prostate cancer or those who have already been diagnosed with advanced prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and personalized prostate cancer screening, reducing unnecessary treatments and improving outcomes for patients.
How similar studies have performed: Previous research has shown promise in risk-stratified screening approaches, but this specific method focusing on a diverse population is relatively novel.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Langston, Marvin Epolian — Stanford University
- Study coordinator: Langston, Marvin Epolian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.